Bridget Stroup

Currently working with: Denise Ney
Undergraduate Degree: UW-Madison

Bridget’s PhD work involves characterizing the clinical outcomes of the elemental amino acid diet compared with the glycomacropeptide diet in humans with PKU, in addition to how dietary protein source impacts bone, renal net acid excretion, and urinary calcium excretion in the PKU mouse model.


  1. Sawin EA, De Wolfe TJ, Aktas B, Stroup BM, Murali SG and Ney DM.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol (Gastrointest Liver Physiol) 309:G590-G601, 2015. DOI 10.1152/ajpgi.00211, 2015. PMCID: PMC4593820
  2. Stroup BM, Held PK, Williams P, Clayton MK, Murali SG, Rice GM, Ney DM. Clinical relevance of the discrepancy in phenylalanine concentration analyzed using tandem mass spectrometry compared with ion-exchange chromatography in phenylketonuria. Mol Genet Metab Rep 6:21-26, 2016. PMCID: PMC4789345
  3. Ney DM, Stroup BM, et al.  Glycomacropeptide for nutritional management of phenylketonuria:  a randomized, controlled, crossover trial. Am J Clin Nutr 104:334-45, 2016.  Free Access PMCID: PMC4962165
  4. Sawin EA, Stroup BM, Murali SG, O’Neil LM, Ntambi JM, Ney DM. Differential effects of dietary fat and protein source on bone phenotype and fatty acid oxidation in female C57Bl/6 mice. PLoSOne 11:1-33, 2016. DOI 10.1371/journal.pone.0163234. PMC: 27695036